BRWA
BMY.RT

B. Riley Wealth Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

B. Riley Wealth Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,061
Closed -$9K – 1443
2020
Q4 		$9K Sell
12,061
-4,160
-26% -$8.86K ﹤0.01% 1025
2020
Q3 		$41K Buy
16,221
+3,194
+25% +$9.12K ﹤0.01% 926
2020
Q2 		$47K Buy
13,027
+46
+0.4% +$166 ﹤0.01% 844
2020
Q1 		$50K Sell
12,981
-384
-3% -$1.26K ﹤0.01% 757
2019
Q4 		$41K Buy
+13,365
New +$34.8K ﹤0.01% 816

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

B. Riley Wealth Advisors's BMY.RT Position: Q1 2021 in Review

B. Riley Wealth Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 12,061 shares — an estimated $9K sold.

B. Riley Wealth Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $50K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • B. Riley Wealth Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 12,061 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
  • B. Riley Wealth Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $50K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2021, filed 13 May 2021.